Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dermatological manifestations associated with COVID-19 and COVID-19 vaccination: results from the Lebanese COVID registry.
Chrabieh R, Haddad I, Salameh P, Kurban M, Kechichian E, Habre M, Ayoub N, Torbey G, El Sayed F, Maamari M, Tannous Z, Farra A; Lebanese COVID Rash Consortium; El Khoury J. Chrabieh R, et al. Among authors: tannous z. Int J Dermatol. 2023 Oct;62(10):1248-1256. doi: 10.1111/ijd.16815. Epub 2023 Aug 28. Int J Dermatol. 2023. PMID: 37638543
Large area fractional laser treatment of mouse skin increases energy expenditure.
Salma N, Wang-Evers M, Karasik D, Yerevanian A, Downs H, Luo T, Doyle AE, Tannous Z, Cacicedo JM, Manstein D. Salma N, et al. Among authors: tannous z. iScience. 2023 Dec 7;27(1):108677. doi: 10.1016/j.isci.2023.108677. eCollection 2024 Jan 19. iScience. 2023. PMID: 38213618 Free PMC article.
Mouse model of selective cryolipolysis.
Salma N, Wang-Evers M, Casper MJ, Karasik D, Andrade YJ, Tannous Z, Manstein D. Salma N, et al. Among authors: tannous z. Lasers Surg Med. 2023 Jan;55(1):126-134. doi: 10.1002/lsm.23573. Epub 2022 Jul 12. Lasers Surg Med. 2023. PMID: 35819225
Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial.
Andreas S, Testa M, Boyer L, Brusselle G, Janssens W, Kerwin E, Papi A, Pek B, Puente-Maestu L, Saralaya D, Watz H, Wilkinson TMA, Casula D, Di Maro G, Lattanzi M, Moraschini L, Schoonbroodt S, Tasciotti A, Arora AK, Maltais F; NTHi-Mcat-002 study group. Andreas S, et al. Lancet Respir Med. 2022 May;10(5):435-446. doi: 10.1016/S2213-2600(21)00502-6. Epub 2022 Jan 10. Lancet Respir Med. 2022. PMID: 35026180 Clinical Trial.
56 results